van West D, Maes M. Activation of the inflammatory response system: A new look at the etiopathogenesis of major depression.  Neuro Endocrinol Lett. 1999 Jan;  20(1-2): 11-17

Maes M, Jirakran K, Vasupanrajit A, Zhou B, Tunvirachaisakul C, Stoyanov D, Almulla A. Are abnormalities in lipid metabolism, together with adverse childhood experiences, the silent causes of immune-linked neurotoxicity in major depression?  Neuro Endocrinol Lett. 2024 Dec;  45(6): 393-408

Maes M, Vasupanrajit A, Jirakran K, Zhou B, Tunvirachaisakul C, Almulla A. First-episode mild depression in young adults is a pre-proatherogenic condition even in the absence of subclinical metabolic syndrome: lowered lecithin-cholesterol acyltransferase as a key factor.  Neuro Endocrinol Lett. 2024 Dec;  45(7-8): 475-491

Maes M, Almulla A, Vojdani E, Dzhambazova E, Stoyanov D, Zhang Y, Vojdani A. Chronic fatigue syndrome, depression, and anxiety symptoms due to relapsing-remitting multiple sclerosis are associated with reactivation of Epstein-Barr virus and Human Herpesvirus 6.  Neuro Endocrinol Lett. 2025 Apr;  46(1): 15-26

Maes M, Jirakran K, Semeão L, Michelin A, Matsumoto A, Brinholi F, Barbosa D, Tivirachaisakul C, Almulla A, Stoyanov D, Zhang Y. Key factors underpinning neuroimmune-metabolic-oxidative (NIMETOX) major depression in outpatients: paraoxonase 1 activity, reverse cholesterol transport, increased atherogenicity, protein oxidation, and differently expressed cytokine networks.  Neuro Endocrinol Lett. 2025 Sep;  46(2): 115-125